Warner Chilcott to limit DTC, rely more on reps

Share this article:
Warner Chilcott said it would “make much more limited use of DTC in support of our existing brands,” relying instead on reps to drive market share gains. In a Q2 results statement, the company said advertising and promotion expenses were down $12.1 million, or 54% for the quarter, compared to Q2 2007, mainly on a reduction in DTC. The firm continues to air TV ads for its Loestrin 24. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.